Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
Recruiting
- Conditions
- Bladder Cancer
- Interventions
- Other: Registry
- Registration Number
- NCT03413982
- Lead Sponsor
- University of Kansas Medical Center
- Brief Summary
The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
- Patients who present to clinic with presumed bladder cancer or have a diagnosis of bladder cancer are eligible to participate
- Patients can participate in any additional research studies during the patients' participation within this protocol.
Exclusion Criteria
- Patients who do not have presumed bladder cancer will not be eligible
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description BC Patients Registry Patients with bladder cancer. This registry involves no intervention. Blood, urine, and tissue samples will be collected to be used for research.
- Primary Outcome Measures
Name Time Method Blood, urine and tissue characteristics of bladder cancer patients 24 months Samples will be collected over a 24 month period for patients to build a biorepository for future research on how they are related to tumor development, recurrence and survival.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Kansas Medical Center
🇺🇸Kansas City, Kansas, United States